Nakano M - Search Results

1

Identification of novel immunohistochemical tumor markers for primary hepatocellular carcinoma; clathrin heavy chain and formiminotransferase cyclodeaminase.

Seimiya M, Tomonaga T, Matsushita K, Sunaga M, Oh-Ishi M, Kodera Y, Maeda T, Takano S, Togawa A, Yoshitomi H, Otsuka M, Yamamoto M, Nakano M, Miyazaki M, Nomura F. Seimiya M, et al. Among authors: nakano m. Hepatology. 2008 Aug;48(2):519-30. doi: 10.1002/hep.22364. Hepatology. 2008. PMID: 18571811

2

Positive glypican-3 expression in early hepatocellular carcinoma predicts recurrence after hepatectomy.

Chen IP, Ariizumi S, Nakano M, Yamamoto M. Chen IP, et al. Among authors: nakano m. J Gastroenterol. 2014 Jan;49(1):117-25. doi: 10.1007/s00535-013-0793-2. Epub 2013 Mar 27. J Gastroenterol. 2014. PMID: 23532638 Free PMC article.

3

Immunohistological evaluation of single small hepatocellular carcinoma with negative staining of monoclonal antibody Hepatocyte Paraffin 1.

Sugiki T, Yamamoto M, Aruga A, Takasaki K, Nakano M. Sugiki T, et al. Among authors: nakano m. J Surg Oncol. 2004 Nov 1;88(2):104-7. doi: 10.1002/jso.20144. J Surg Oncol. 2004. PMID: 15499598

4

Clinicopathologic features of patients with intrahepatic cholangiocarcinoma who are seropositive for alpha-fetoprotein-L3 and those with combined hepatocellular and cholangiocarcinoma.

Okuda H, Shiratori K, Yamamoto M, Takasaki K, Nakano M. Okuda H, et al. Among authors: nakano m. J Gastroenterol Hepatol. 2006 May;21(5):869-73. doi: 10.1111/j.1440-1746.2006.04257.x. J Gastroenterol Hepatol. 2006. PMID: 16704538

5

Specific characteristics of scirrhous hepatocellular carcinoma.

Sugiki T, Yamamoto M, Taka K, Nakano M. Sugiki T, et al. Among authors: nakano m. Hepatogastroenterology. 2009 Jul-Aug;56(93):1086-9. Hepatogastroenterology. 2009. PMID: 19760947

6

Clinicopathologic features of patients with hepatocellular carcinoma seropositive for alpha-fetoprotein-L3 and seronegative for des-gamma-carboxy prothrombin in comparison with those seropositive for des-gamma-carboxy prothrombin alone.

Okuda H, Nakanishi T, Takatsu K, Saito A, Hayashi N, Yamamoto M, Takasaki K, Nakano M. Okuda H, et al. Among authors: nakano m. J Gastroenterol Hepatol. 2002 Jul;17(7):772-8. doi: 10.1046/j.1440-1746.2002.02806.x. J Gastroenterol Hepatol. 2002. PMID: 12121507

7

Intrahepatic cholangiocarcinoma diagnosed preoperatively as hepatocellular carcinoma.

Yamamoto M, Ariizumi S, Otsubo T, Katsuragawa H, Katagiri S, Nakano M, Takasaki K. Yamamoto M, et al. Among authors: nakano m. J Surg Oncol. 2004 Aug 1;87(2):80-3; discussion 83-4. doi: 10.1002/jso.20091. J Surg Oncol. 2004. PMID: 15282700

8

Intrahepatic cholangiocarcinoma.

Nakano M, Ariizumi SI, Yamamoto M. Nakano M, et al. Semin Diagn Pathol. 2017 Mar;34(2):160-166. doi: 10.1053/j.semdp.2016.12.012. Epub 2017 Jan 5. Semin Diagn Pathol. 2017. PMID: 28094162

9

Extent of resection for hepatocellular carcinoma 2 cm or less in greatest diameter.

Yamamoto M, Takasaki K, Otsubo T, Saito A, Nakano M. Yamamoto M, et al. Among authors: nakano m. Am J Surg. 2002 Nov;184(5):437-40. doi: 10.1016/s0002-9610(02)01005-x. Am J Surg. 2002. PMID: 12433609

10

Clinicopathologic features of patients with primary malignant hepatic tumors seropositive for alpha-fetoprotein-L3 alone in comparison with other patients seropositive for alpha-fetoprotein-L3.

Okuda H, Saito A, Shiratori K, Yamamoto M, Takasaki K, Nakano M. Okuda H, et al. Among authors: nakano m. J Gastroenterol Hepatol. 2005 May;20(5):759-64. doi: 10.1111/j.1440-1746.2005.03773.x. J Gastroenterol Hepatol. 2005. PMID: 15853991

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,411 results

Search Page

Filters